{"title":"The Effects of Nurses’ Attitudes and Behaviors Toward End-of-life Care on Clinical Decision-making","authors":"Saadet Erzincanlı, Kadriye Sayin Kasar","doi":"10.4274/tybd.galenos.2021.00710","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.00710","url":null,"abstract":"","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2022-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75758949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Khin Zar Li Aung, Rabia Yılmaz, Ezgi Güngördü, S. Aşar, Yasemin Tekdos Şeker
{"title":"Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?","authors":"Khin Zar Li Aung, Rabia Yılmaz, Ezgi Güngördü, S. Aşar, Yasemin Tekdos Şeker","doi":"10.4274/tybd.galenos.2021.04706","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.04706","url":null,"abstract":"E-mail : drrabiayilmaz@gmail.com Phone : +90 539 840 27 19 ORCID ID : orcid.org/0000-0003-1707-4607 ABSTRACT Objective: Although there is no antiviral treatment specific to the virus, favipiravir has entered the treatment routine as an antiviral in our country in May 2020. In this study, in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acute respiratory distress syndrome (ARDS) in the intensive care unit; The effects of favipiravir antiviral regimen on mortality and morbidity were evaluated. Materials and Methods: Patients admitted to the intensive care unit were divided into two groups as those who received favipiravir (group F; n=208) and those who did not (group N; n=101). The treatment of the cases is arranged according to current national guidelines. Metavision/QlinICU Clinical Decision Support Software, in intensive care unit; Acute Physiology and Chronic Health Evaluation-II, Sequential Organ Failure Assessment score, aspartate aminotransferase, alanine aminotransferase, urea, creatinine, lactate dehydrogenase, ferritin, C-reactive protein (CRP), procalcitonin, Pro-BNP, D-dimer, fibrinogen, white blood cell, neutrophil count (NEU), lymphocyte count (LYM), NEU/LYM, CRP, t1 acceptance (0th hour), t2 follow-up (24th hour) and t3 (discharge or ex) values of acute phase parameters, and the comorbidity is obtained by Structured Query Language queries. The primary outcome is mortality; secondary outcomes are possible drugrelated organ toxicities, sudden change of the level of the acute phase reactants, requirement of continuous renal replacement therapy (CRRT), hospitalization time, ventilator dependent days. Results: One hundred eight women (35%), 201 men (65%), a total of 309 cases were evaluated in the study. In the demographic data of the groups, no statistically significant difference was found between the frequency of comorbidity, mortality rate, CRRT need, and secondary infection. The mean increase of 107.66±628.99 units between the t1 and t3 measurement was found to be statistically significant in F group cases. In the F group, the neutrophil/lymphocyte ratio (NLR) during the follow-up period and the last NLR were found to be lower than the initial value. Conclusion: It was determined that favipiravir used in the treatment of SARS-CoV-2 ARDS has no superiority in preventing mortality.","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85447669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mehtap Pehlivanlar Küçük, Burcu Öksüz Güngör, A. Küçük, O. Ayçiçek, Atila Türkyılmaz, Funda Öztuna, Y. Bülbül, T. Özlü
{"title":"Pneumothorax and Subcutaneous Emphysema Evaluation in Patients with COVID-19 in the Intensive Care Unit","authors":"Mehtap Pehlivanlar Küçük, Burcu Öksüz Güngör, A. Küçük, O. Ayçiçek, Atila Türkyılmaz, Funda Öztuna, Y. Bülbül, T. Özlü","doi":"10.4274/tybd.galenos.2021.30316","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.30316","url":null,"abstract":"E-mail : mehtap_phlvnlr@hotmail.com Phone : +90 505 242 44 90 ORCID ID : orcid.org/0000-0003-2247-4074 ABSTRACT Objective: Pneumothorax (PNX) and subcutaneous emphysema (SCE) have increased in importance as a frequently occurring complication. This study aimed to reveal the frequency, timing, and possible risk factors in patients with PNX and SCE who are followed up with coronavirus disease-2019 (COVID-19) diagnosis in our tertiary intensive care unit (ICU). Materials and Methods: All patients with confirmed COVID-19 who were followed up and treated in our unit between August 8, 2020, and February 20, 2021, in a 16-bed tertiary ICU and who developed PNX and SCE during their hospitalization were included. Results: PNX and SCE developed in 16 (9.6%) of 165 patients who were followed up in our ICU due to COVID-19. Of these 16 patients, 3 (18.8%) survived. The median age of patients was 66.5 years (interquartile range: 58.5-75.5). Diabetes mellitus was the most common comorbidity in patients with PNX and SCE. Additionally, 12 (75%) patients had a smoking history. Of 15 (93.8%) patients who developed PNX, 4 (25%) were bilateral, and SCE developed in 9 (56.3%) patients. Twelve (75%) patients with PNX and SCE were under invasive mechanical ventilation, 3 (18.8%) under spontaneous breathing, and 1 (6.2%) under non-invasive mechanical ventilation treatment. The number of oxygen support days until the time PNX and SCE developed was 9 (6.25-17) days in the whole group, the median time was 6 days in the survival group and 9 days in the non-survival group. Conclusion: In the COVID-19 pandemic, complications, such as PNX and SCE, are more frequently observed (9.5%) than in the general intensive care population and the later period of intensive care admission (median 9 days). Smoking is defined as a risk factor in most of these patients; however, increased PNX rates are thought to be related to both COVID-19 pneumonia and parenchymal damage due to cytokine storms.","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86090273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anıl Kuvandık, Ecenur Özcan, S. Seri̇n, H. Sungurtekin
{"title":"Creutzfeldt-Jakob Disease After the COVID-19 Vaccination","authors":"Anıl Kuvandık, Ecenur Özcan, S. Seri̇n, H. Sungurtekin","doi":"10.4274/tybd.galenos.2021.91885","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.91885","url":null,"abstract":"Reports of neurological problems are increasing for the clinical presentation of coronavirus disease-2019 (COVID-19). The clinical presentation reported in this study seemed to be a combination of nonspecific complications of the systemic disease, inflammation of the cerebrovascular system, and the effects of a direct viral infection. Creutzfeldt-Jakob disease, a spongiform encephalopathy caused by prions, is characterized by a severe neurological destruction, which has an extremely high mortality. In this publication, we presented a patient who was admitted to the Pamukkale University Anesthesiology Intensive Care Units with the neurological findings that developed after the COVID-19 vaccine (CoronaVac, Sinovac Life Sciences, Beijing, China). The patient died due to the progressive neurological disorders. In cases where rapidly progressive neurological disorders are observed, Creutzfeldt-Jakob disease should be considered and the role of immunity-related conditions in the progression of the disease should be investigated. (English) [ FROM AUTHOR] Koronavirüs hastalığı-2019 (COVID-19) hastalığının klinik seyrinde gelişen nörolojik problemlerle ilgili raporlar artmaktadır. Bu klinik tablo, sistemik hastalığın spesifik olmayan komplikasyonları, serebrovasküler sistem iltihabı veya doğrudan viral enfeksiyonun etkilerinin bir kombinasyonu gibi görünmektedir. Prionların neden olduğu süngerimsi bir ensefalopati olan Creutzfeldt-Jakob hastalığı, şiddetli nörolojik yıkım ile karakterizedir ve son derece yüksek bir ölüm oranına sahiptir. Bu yayında, Pamukkale Üniversitesi Anesteziyoloji Yoğun Bakım Ünitesi’ne COVID-19 aşısı (CoronaVac, Sinovac Life Sciences, Beijing, China) sonrası gelişen nörolojik bulgularla başvuran bir hastayı sunduk. Hasta ilerleyici nörolojik bozukluklar nedeniyle öldü. Hızla ilerleyen nörolojik bozuklukların görüldüğü durumlarda Creutzfeldt-Jakob hastalığı düşünülmeli ve bağışıklıkla ilgili durumların hastalığın ilerlemesindeki rolü araştırılmalıdır. (Turkish) [ FROM AUTHOR] Copyright of Turkish Journal of Intensive Care is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77982874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fatma Irem Yesiler, Çağla Yazar, İrem Ulutaş Ordu, Helin Şahintürk, Tuğba Yanık Yalçın, P. Zeyneloğlu
{"title":"Evaluation of Sepsis and Extensively Drug Resistant Infections in Deceased Critically Ill Patients","authors":"Fatma Irem Yesiler, Çağla Yazar, İrem Ulutaş Ordu, Helin Şahintürk, Tuğba Yanık Yalçın, P. Zeyneloğlu","doi":"10.4274/tybd.galenos.2021.62533","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.62533","url":null,"abstract":"","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87870534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y. Uğur, Murathan Küçük, M. C. Öztürk, Bilgin Cömert, N. Gokmen, B. Ergan
{"title":"Treatment Change and Prognosis Effect of Fiberoptic Bronchoscopic Sampling in the Intensive Care Unit","authors":"Y. Uğur, Murathan Küçük, M. C. Öztürk, Bilgin Cömert, N. Gokmen, B. Ergan","doi":"10.4274/tybd.galenos.2021.60783","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.60783","url":null,"abstract":"","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72443558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Ece, Ş. Canlı, Fatih Balaban, D. Aslan, D. Engin
{"title":"Case Report: A Rare Cause of Ischemic Stroke in the Intensive Care Unit: Venous Sinus Thrombosis","authors":"C. Ece, Ş. Canlı, Fatih Balaban, D. Aslan, D. Engin","doi":"10.4274/tybd.galenos.2021.80774","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.80774","url":null,"abstract":"","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78296798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cem Erdoğan, Sibel Doğan, Rumeysa Çakmak, O. Olmuşçelik, Deniz Kızılaslan, B. Çiftçi
{"title":"Anxiety Evaluation Between Doctors Providing Coronavirus Disease-2019 and Noncoronavirus Disease-2019-related Services","authors":"Cem Erdoğan, Sibel Doğan, Rumeysa Çakmak, O. Olmuşçelik, Deniz Kızılaslan, B. Çiftçi","doi":"10.4274/tybd.galenos.2021.02419","DOIUrl":"https://doi.org/10.4274/tybd.galenos.2021.02419","url":null,"abstract":"","PeriodicalId":40562,"journal":{"name":"Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2021-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82820566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}